Home / Inspections / 1252280

FDA Inspection 1252280 — Wyeth Pharmaceutical Division of Wyeth Holdings LLC

Wyeth Pharmaceutical Division of Wyeth Holdings LLC — FEI 1000110954

The FDA completed an inspection of Wyeth Pharmaceutical Division of Wyeth Holdings LLC on October 17, 2024 in Sanford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 17, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Sanford, NC (United States)

Facility

Other inspections at this facility

  • 1192736 (VAI Fri Nov 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1121288 (VAI Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1051716 (VAI Thu Apr 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 989301 (VAI Thu Aug 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904925 (VAI Wed Jul 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources